| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3801224 | Medicina Clínica | 2009 | 5 Pages |
Abstract
CRP is a marker of increased IMT in patients with atherothrombotic ischemic stroke. A cutoff point of 1.5Â mg/dl for CRP provided a greater IMT and a worse outcome in functional disability as cardiovascular risk. Therefore, this group requires a more intensive treatment in secondary prevention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jose Carlos Arévalo Lorido, Juana Carretero Gómez,